Skip to main content
Main menu
About
Our Mission
Donors
Board of Directors
Advisory Boards
Staff
Careers
Who we are
FAQ
Annual Report
Why New TB Drugs?
Global Pandemic
Inadequate Treatment
Antimicrobial Resistance
Maternal and Child Health
Cycle of Poverty
R&D
Scientific Vision
Pipeline
Discovery
Engaging Communities
Access
Our Commitment
Access in TB Market
Child-friendly medicines
Pretomanid and BPaL
Pathways to Access BPaL
News
Latest News
Publications
Voices of TB
Research Papers
Making an Impact
Donate
Search form
Search
News Archive
July 1, 2006
Wird Gates' Stiftung zu mächtig?
June 18, 2006
Global Health Innovation
June 1, 2006
Overcoming Tuberculosis: New Treatments on the Horizon
June 1, 2006
Drug Development Panel at the Global Health Conference
May 29, 2006
UNGASS Briefing Draws Attention to TB/HIV Co-infection
May 28, 2006
Gates Foundation, Novartis embark on public-private ventures to combat TB and malaria
May 25, 2006
Gatesin säätiöltä sata miljoonaa tuberkuloosin vastaiseen taisteluun (Finnish)
May 24, 2006
Gates Foundation to donate USD 104 million to TB Alliance
May 24, 2006
Cuantiosa donación de Gates contra la tuberculosis
May 24, 2006
Gates Donates $104 Million To TB Charity
Pages
«
‹
…
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
…
›
»
